|

Monitoring Effect Of Shock Wave On Microcirculation Changes In Type2 Diabetes Mellitus

RECRUITINGN/ASponsored by South Valley University
Actively Recruiting
PhaseN/A
SponsorSouth Valley University
Started2024-03-01
Est. completion2024-03-25
Eligibility
Age40 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06159192

Summary

The purpose of the study is to monitor the effect of low intensity extracorporeal shock wave therapy on impaired nitric oxide synthase and microcirculation changes in type 2 diabetes mellitus with peripheral neuropathy.

Eligibility

Age: 40 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
* Optimized pharmacological treatment that will be remained unchanged throughout the study.

Exclusion Criteria:

* Implanted cardiac pacemakers.
* Patients with known skin allergies.
* Presence of skin inflammations.
* Peripheral vascular disease.
* Patients with unstable angina pectoris.
* Progressive ventricular dysrhythmia.
* Intermittent claudication.

Conditions2

DiabetesShock Wave and Nitric Oxide

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.